You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren’s syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?

Citation Tools

Article menu

Download PDFPDF

XML
Sjögren syndrome
Short report
Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren’s syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Blokland SLM, Hillen MR, Wichers CGK, et al
Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren’s syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
RMD Open 2019;5:e000701. doi: 10.1136/rmdopen-2018-000701